Products - Diabetes | Topic | NICE

Showing 7 products

Date | Title

Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

Semaglutide for treating type 2 diabetes (ID1450)
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Dulaglutide for treating type 2 diabetes [ID1451]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Sotagliflozin for treating type 2 diabetes [ID1657]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Ranibizumab port delivery system for treating diabetic macular oedema ID6137
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Canagliflozin for treating type 2 diabetes in people 10 to 17 years TS ID 11888
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
LY3209590 for treating type 2 diabetes in people on daily insulin injections [ID6499]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
LY3209590 for treating type 1 diabetes in people on multiple daily insulin injections [ID6498]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC